Integrated Wealth Concepts LLC Grows Stock Position in Addus HomeCare Corporation $ADUS

Integrated Wealth Concepts LLC increased its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUSFree Report) by 8.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,844 shares of the company’s stock after buying an additional 596 shares during the quarter. Integrated Wealth Concepts LLC’s holdings in Addus HomeCare were worth $776,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the business. WCM Investment Management LLC lifted its position in Addus HomeCare by 4.9% during the first quarter. WCM Investment Management LLC now owns 494,791 shares of the company’s stock worth $48,143,000 after buying an additional 23,176 shares during the period. Principal Financial Group Inc. lifted its position in Addus HomeCare by 18.3% during the first quarter. Principal Financial Group Inc. now owns 475,818 shares of the company’s stock worth $47,054,000 after buying an additional 73,720 shares during the period. Wellington Management Group LLP lifted its position in Addus HomeCare by 25.8% during the first quarter. Wellington Management Group LLP now owns 471,935 shares of the company’s stock worth $46,670,000 after buying an additional 96,823 shares during the period. Invesco Ltd. lifted its position in Addus HomeCare by 19.8% during the first quarter. Invesco Ltd. now owns 414,705 shares of the company’s stock worth $41,010,000 after buying an additional 68,585 shares during the period. Finally, Northern Trust Corp raised its holdings in shares of Addus HomeCare by 6.7% in the 1st quarter. Northern Trust Corp now owns 305,109 shares of the company’s stock worth $30,172,000 after purchasing an additional 19,237 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Addus HomeCare

In related news, EVP Brian Poff sold 7,739 shares of the firm’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $116.82, for a total transaction of $904,069.98. Following the sale, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. This trade represents a 11.96% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total value of $2,873,750.00. Following the sale, the chief executive officer owned 166,461 shares in the company, valued at approximately $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 34,310 shares of company stock worth $3,958,375. 4.50% of the stock is currently owned by company insiders.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $110.27 on Friday. The company has a market cap of $2.03 billion, a P/E ratio of 24.34, a PEG ratio of 1.71 and a beta of 0.85. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72. The business’s 50-day simple moving average is $111.98 and its 200 day simple moving average is $107.13.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.45 by $0.04. The business had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The company’s revenue was up 21.8% on a year-over-year basis. During the same period last year, the business posted $1.35 EPS. On average, sell-side analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of research reports. Barclays raised their price objective on Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a report on Tuesday, August 19th. Royal Bank Of Canada raised their price objective on Addus HomeCare from $133.00 to $134.00 and gave the stock an “outperform” rating in a report on Friday, August 22nd. UBS Group initiated coverage on Addus HomeCare in a report on Tuesday, September 2nd. They issued a “buy” rating and a $145.00 price objective on the stock. TD Cowen raised their price objective on Addus HomeCare from $135.00 to $139.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Finally, JMP Securities restated a “market outperform” rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $138.89.

View Our Latest Stock Analysis on ADUS

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.